204 related articles for article (PubMed ID: 11179673)
21. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
[TBL] [Abstract][Full Text] [Related]
22. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.
Sigvardsson M; Clark DR; Fitzsimmons D; Doyle M; Akerblad P; Breslin T; Bilke S; Li R; Yeamans C; Zhang G; Hagman J
Mol Cell Biol; 2002 Dec; 22(24):8539-51. PubMed ID: 12446773
[TBL] [Abstract][Full Text] [Related]
23. A two-step mechanism for recruitment of Pip by PU.1.
Perkel JM; Atchison ML
J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
[TBL] [Abstract][Full Text] [Related]
24. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
25. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.
Roberts EC; Deed RW; Inoue T; Norton JD; Sharrocks AD
Mol Cell Biol; 2001 Jan; 21(2):524-33. PubMed ID: 11134340
[TBL] [Abstract][Full Text] [Related]
26. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.
Bassuk AG; Anandappa RT; Leiden JM
J Virol; 1997 May; 71(5):3563-73. PubMed ID: 9094628
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
[TBL] [Abstract][Full Text] [Related]
28. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function.
Grant PA; Thompson CB; Pettersson S
EMBO J; 1995 Sep; 14(18):4501-13. PubMed ID: 7556093
[TBL] [Abstract][Full Text] [Related]
29. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
[TBL] [Abstract][Full Text] [Related]
30. The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes.
Wheat W; Fitzsimmons D; Lennox H; Krautkramer SR; Gentile LN; McIntosh LP; Hagman J
Mol Cell Biol; 1999 Mar; 19(3):2231-41. PubMed ID: 10022910
[TBL] [Abstract][Full Text] [Related]
31. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
32. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
Dörfler P; Busslinger M
EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
[TBL] [Abstract][Full Text] [Related]
33. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
34. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
35. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.
Maier H; Colbert J; Fitzsimmons D; Clark DR; Hagman J
Mol Cell Biol; 2003 Mar; 23(6):1946-60. PubMed ID: 12612069
[TBL] [Abstract][Full Text] [Related]
36. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S; Park K; Farrar MA; Atchison ML
J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of Elf-1: locus-wide analysis reveals four distinct promoters, a tissue-specific enhancer, control by PU.1 and the importance of Elf-1 downregulation for erythroid maturation.
Calero-Nieto FJ; Wood AD; Wilson NK; Kinston S; Landry JR; Göttgens B
Nucleic Acids Res; 2010 Oct; 38(19):6363-74. PubMed ID: 20525788
[TBL] [Abstract][Full Text] [Related]
38. Human monocyte/neutrophil elastase inhibitor (MNEI) is regulated by PU.1/Spi-1, Sp1, and NF-kappaB.
Zeng W; Remold-O'Donnell E
J Cell Biochem; 2000 Jun; 78(4):519-32. PubMed ID: 10861849
[TBL] [Abstract][Full Text] [Related]
39. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
[TBL] [Abstract][Full Text] [Related]
40. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
